Skip to main navigation Skip to search Skip to main content

A turning point in hepatology? EASL reflects on the first approved drug for MASH

  • Sven Francque
  • , Aleksander Krag*
  • , Debbie L. Shawcross
  • , Shira Zelber-Sagi
  • *Corresponding author for this work
  • Antwerp University Hospital
  • University of Antwerp
  • King's College London
  • University of Haifa

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish
JournalJournal of Hepatology
Volume81
Issue number2
Pages (from-to)192-194
ISSN0168-8278
DOIs
Publication statusPublished - Aug 2024

Keywords

  • Antibodies, Monoclonal, Humanized/therapeutic use
  • Drug Approval
  • Europe
  • Gastroenterology/methods
  • Humans

Cite this